- Report
- July 2025
- 350 Pages
Global
From €4477EUR$4,949USD£3,834GBP
- Report
- March 2026
- 150 Pages
Global
From €2442EUR$2,699USD£2,091GBP
- Report
- March 2026
- 200 Pages
Global
From €2523EUR$2,789USD£2,161GBP
- Report
- August 2025
- 168 Pages
Global
From €3256EUR$3,599USD£2,788GBP
- Report
- May 2026
- 136 Pages
Global
From €3618EUR$3,999USD£3,098GBP
- Report
- April 2026
- 135 Pages
Global
From €3618EUR$3,999USD£3,098GBP
- Report
- April 2026
- 150 Pages
Global
From €3618EUR$3,999USD£3,098GBP
- Report
- April 2026
- 149 Pages
Global
From €3618EUR$3,999USD£3,098GBP
- Report
- April 2026
- 145 Pages
Global
From €3618EUR$3,999USD£3,098GBP
- Report
- April 2026
- 143 Pages
Global
From €3618EUR$3,999USD£3,098GBP
- Report
- April 2026
- 115 Pages
Global
From €4297EUR$4,750USD£3,680GBP
- Report
- April 2026
- 180 Pages
Global
From €4297EUR$4,750USD£3,680GBP
- Report
- January 2026
- 120 Pages
Global
From €4297EUR$4,750USD£3,680GBP
- Report
- December 2025
- 200 Pages
Global
From €7192EUR$7,950USD£6,159GBP
- Report
- November 2025
- 200 Pages
Global
From €7192EUR$7,950USD£6,159GBP
- Report
- November 2025
- 200 Pages
Global
From €7192EUR$7,950USD£6,159GBP
- Report
- April 2026
- 140 Pages
Global
From €3618EUR$3,999USD£3,098GBP
- Report
- April 2026
- 148 Pages
Global
From €3618EUR$3,999USD£3,098GBP
- Report
- February 2026
- 305 Pages
Global
From €2262EUR$2,500USD£1,937GBP
- Report
- January 2026
- 299 Pages
Global
From €2262EUR$2,500USD£1,937GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more